New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

BACKGROUND: In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (CNS) relapse is uncommon but is nearly always fatal. This study aimed to determine the risk factors for CNS relapse in DLBCL patients and to evaluate the efficacy of rituximab and intrathecal chemotherapy pro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chin J Cancer
Hlavní autoři: Cai, Qing-Qing, Hu, Li-Yang, Geng, Qi-Rong, Chen, Jie, Lu, Zhen-Hai, Rao, Hui-Lan, Liu, Qing, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5022242/
https://ncbi.nlm.nih.gov/pubmed/27624700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0150-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky